Clinical trial Recruiting at 1 site Interventional Ages 30 to 59

Comparing short sprint cycling vs moderate continuous cycling to lower blood pressure in people with hypertension

Official title: Clinical Trial in Hypertensive Patients Comparing Two Cardiorespiratory Exercise Protocols, Low-volume Sprint Interval Training (SIT) Versus Moderate-intensity Continuous Training (MICT), to Evaluate Decreases in Ambulatory Blood Pressure and Other Clinical Variables.

Run by Unidad Enfermedades Cardiometabolicas- Hospital Interzonal General Agudos San Martin de La Plata · NCT07229196 · Data updated 2026-11-12

This trial tests whether brief, intense sprint cycling or longer moderate cycling better lowers 24-hour blood pressure in adults aged 30–59 with hypertension.

Quick facts

Study typeInterventional
Ages30 Years to 59 Years
SexAll
Enrollment20 (estimated)
SponsorUnidad Enfermedades Cardiometabolicas- Hospital Interzonal General Agudos San Martin de La Plata
Academic / other
Locations1 site (La Plata, Buenos Aires)
StatusRecruiting
StartedApril 29, 2025
Main results expectedNovember 2026
Study endsJanuary 2027
Registry record updatedNovember 14, 2025
Trial IDNCT07229196 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 30–59 with diagnosed hypertension (treated or untreated) who are free of high cardiovascular risk conditions and meet the trial's BMI and office blood pressure limits.

Probably not a fit

Patients with high cardiovascular risk (for example diabetes, CKD, coronary or cerebrovascular disease), very high office BP (≥160/100 mmHg), or extreme BMI (<18.5 or ≥35) are unlikely to qualify or benefit from these protocols.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial will enroll adults 30–59 years with diagnosed hypertension and no high cardiovascular risk, randomizing them after a two-week familiarization to either low-volume Sprint Interval Training (SIT) or Moderate-Intensity Continuous Training (MICT). Interventions last 12 weeks with three supervised cycling sessions per week; SIT sessions use 2–4 maximal 20–30 second sprints with recovery (≤15 minutes total) while MICT sessions use 15–30 minutes at 50–70% VO₂max. The primary outcome is change in 24-hour ambulatory systolic blood pressure measured after 12 weeks, with secondary outcomes including diastolic/daytime/nighttime BP, body composition, metabolic profile, VO₂max, hemodynamic measures, handgrip strength, and serum myokines (IL-6 and α-CGRP). All visits and supervised sessions are conducted at the Cardio-Metabolic Disease Unit of Hospital Interzonal General de Agudos San Martín in La Plata, Argentina.

Why it matters

Potential benefit: If successful, this could offer a time-efficient exercise option that lowers 24-hour blood pressure and improves metabolic and vascular health for people with hypertension.

How similar studies have gone: Prior studies in other populations have shown SIT can improve fitness and some cardiometabolic markers, but few randomized trials have tested SIT in hypertensive patients using 24-hour ambulatory blood pressure monitoring.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients of both sexes between 30-59 years of age who meet the definition of hypertension.

Hypertension will be defined as:

1. Those patients who report a history of hypertension and are under pharmacological treatment for it (Angiotensin Converting Enzyme Inhibitors/Angiotensin II Receptor Antagonists/Calcium Channel Blockers/Thiazide Diuretics/Beta Blockers) at the time of the evaluation.

   OR
2. Patients who report a history of hypertension during the evaluation and who, without pharmacological treatment, have average levels ≥140/90 mmHg will also be considered hypertensive.

Exclusion Criteria:

* Extreme body mass index (BMI) \<18.5 and ≥35.
* Patients with office blood pressure readings ≥160/100 mmHg.
* Patients with high cardiovascular risk conditions such as type II diabetes, chronic kidney disease (\<60 milliseconds), history of cerebrovascular disease, coronary artery disease, peripheral arterial disease, or heart failure (Framingham Criteria clinical diagnosis).
* Pregnant or postpartum women up to 3 months old.
* Patients with psychophysical limitations that make exercise difficult.
* Patients with a history of active malignant neoplastic disease under treatment.

Elimination Criteria

-Patients whose pharmacological treatment is initiated or modified during the follow-up after 3 months.

Where it's running

  • Hospital Interzonal General San Martin La Plata
    La Plata, Buenos Aires, Argentina
    Recruiting

Study contacts

  • Principal investigator: Walter Espeche — Hospital Interzonal General San Martin
  • Study coordinator: Julian Minetto, Physican
  • Email: jjminetto@hotmail.com
  • Phone: +542214835429

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.